| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9be712d6dbdaa4c2dd1981caeae59ed4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-16 |
| filingDate |
2001-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7f0f021cd141c8562aa24ed056238b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9619a50a02c76d4f859d085ec068a020
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_011880fe4e6d4fe733d4a539e91626ef |
| publicationDate |
2007-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1752170-A1 |
| titleOfInvention |
Medical technical product, method of production and provision in surgery |
| abstract |
An adhesive prophylaxis medical product for the postoperative prevention of adhesions in the body comprises at least one PVA (polyvinyl alcohol) selected from the group consisting of uncrosslinked PVA having a molecular weight of 15,000 to 400,000, cross-linked PVA, and mixtures thereof. The molecular weight of the PVA or of the mixture is chosen such that it can be excreted via the kidney essentially without degradation of the PVA molecules. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102009029717-A1 |
| priorityDate |
2000-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |